Cyclin D as a therapeutic target in cancer

EA Musgrove, CE Caldon, J Barraclough… - Nature Reviews …, 2011 - nature.com
Cyclin D1, and to a lesser extent the other D-type cyclins, is frequently deregulated in cancer
and is a biomarker of cancer phenotype and disease progression. The ability of these …

Ca2+ signalling checkpoints in cancer: remodelling Ca2+ for cancer cell proliferation and survival

HL Roderick, SJ Cook - Nature Reviews Cancer, 2008 - nature.com
Increases in cytosolic free Ca2+ ([Ca2+] i) represent a ubiquitous signalling mechanism that
controls a variety of cellular processes, including proliferation, metabolism and gene …

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

C Sotiriou, SY Neo, LM McShane… - Proceedings of the …, 2003 - National Acad Sciences
Comprehensive gene expression patterns generated from cDNA microarrays were
correlated with detailed clinico-pathological characteristics and clinical outcome in an …

Modelling breast cancer: one size does not fit all

T Vargo-Gogola, JM Rosen - Nature Reviews Cancer, 2007 - nature.com
Breast cancer is not a single disease, but is instead a collection of diseases that have
distinct histopathological features, genetic and genomic variability, and diverse prognostic …

Pten in stromal fibroblasts suppresses mammary epithelial tumours

AJ Trimboli, CZ Cantemir-Stone, F Li, JA Wallace… - Nature, 2009 - nature.com
The tumour stroma is believed to contribute to some of the most malignant characteristics of
epithelial tumours. However, signalling between stromal and tumour cells is complex and …

[HTML][HTML] Differential gene expression following early renal ischemia/reperfusion

S Supavekin, W Zhang, R Kucherlapati, FJ Kaskel… - Kidney international, 2003 - Elsevier
Differential gene expression following early renal ischemia/reperfusion. Background Acute
renal failure from ischemia/reperfusion injury is associated with tubule cell apoptosis, the …

Mouse models of breast cancer metastasis

A Fantozzi, G Christofori - Breast Cancer Research, 2006 - Springer
Metastatic spread of cancer cells is the main cause of death of breast cancer patients, and
elucidation of the molecular mechanisms underlying this process is a major focus in cancer …

Oncogenes and tumor suppressor genes in breast cancer: potential diagnostic and therapeutic applications

C Osborne, P Wilson, D Tripathy - The oncologist, 2004 - academic.oup.com
Abstract Learning Objectives After completing this course, the reader will be able to:
Differentiate between the actions of oncogenes and tumor suppressor genes in the …

Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells

Y Li, B Welm, K Podsypanina… - Proceedings of the …, 2003 - National Acad Sciences
Breast cancer is a genetically and clinically heterogeneous disease, and the contributions of
different target cells and different oncogenic mutations to this heterogeneity are not well …

Direct evidence for epithelial-mesenchymal transitions in breast cancer

AJ Trimboli, K Fukino, A De Bruin, G Wei, L Shen… - Cancer research, 2008 - AACR
We developed stromal-and epithelial-specific cre-transgenic mice to directly visualize
epithelial-mesenchymal transition (EMT) during cancer progression in vivo. Using three …